Respiporc FLUpan H1N1 European Union - English - EMA (European Medicines Agency)

respiporc flupan h1n1

idt biologika gmbh - inactivated influenza a virus/human - immunologicals, inactivated viral vaccines for pigs, porcine influenza virus - pigs - active immunisation of pigs from the age of 8 weeks onwards against pandemic h1n1 porcine influenza virus to reduce viral lung load and viral excretion.

Syvazul BTV European Union - English - EMA (European Medicines Agency)

syvazul btv

laboratorios syva, s.a.u. - inactivated bluetongue virus, serotype 1, strain alg2006/01 e1, inactivated bluetongue virus, serotype 4, strain btv-4/spa-1/2004, inactivated bluetongue virus, serotype 8, strain bel2006/01 - inactivated viral vaccines - cattle; sheep - for active immunisation of sheep to prevent viraemia and reduce clinical signs and lesions caused by bluetongue virus serotypes 1 and/or 8 and/or to reduce viraemia* and clinical signs and lesions caused by bluetongue virus serotype 4for active immunisation of cattle to prevent viraemia caused by bluetongue virus serotypes 1 and/or 8 and/or to reduce viraemia* caused by bluetongue virus serotype 4.

Suigen PRDC Formulation: Each 1 mL (dose) contains: Bordetella bronchiseptica -1 OD   Bordetella bronchiseptica (DNT)-200 ug/mL Pasteurella multocida (Type A and D)-I OD   P. multocida Type A (OMP)-30 ug/mL Actinobacillus pleuropneumoniae (Serotype 2 and 5)-1 OD   P. multocida Type D (DNT)-200 ug/mL Mycoplasma hvopneumoniae-0.12 OD A. pleuropneumoniae Serotype 2 and 5 (Toxin) 10 ug/mL Streptococcus suis (Type 2)-0.45 OD Haemophilus parasuis (Serotype 1, 4 and 5)-0.45 OD OD - Optical Density at 410 nm absorbance (ELISA) DNT – Dermonecrotic Toxin OMP - Outer Membrane Protein Suspension for   Injection (IM) Philippines - English - FDA (Food And Drug Administration)

suigen prdc formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein suspension for injection (im)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein

Rhiniseng Formulation:   Each 2 mL (dose) contains:   Bordetella bronchiseptica (Strain 833 CER).....................2 x 100 corresponding to 9.8 BbCC Pasteurella multocida Toxin (Type D)...........................110 ug inducing >I MED63   Bordetella bronchiseptica Cell Count (BBCC) Murine Effective Dose 63 (MED) Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

rhiniseng formulation: each 2 ml (dose) contains: bordetella bronchiseptica (strain 833 cer).....................2 x 100 corresponding to 9.8 bbcc pasteurella multocida toxin (type d)...........................110 ug inducing >i med63 bordetella bronchiseptica cell count (bbcc) murine effective dose 63 (med) suspension for injection (im)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida toxin vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (strain 833 cer).....................2 x 100 corresponding to 9.8 bbcc pasteurella multocida toxin (type d)...........................110 ug inducing >i med63 bordetella bronchiseptica cell count (bbcc) murine effective dose 63 (med)

SuiShot APM-7 Each 1 mL (dose) contains:   Pasteurella multocida, Type A (NSPA Strain) ..........   2,000,000,000 CFU Type D (PDNT Strain) ........   ... 2,000,000,000 CFU Actinobacillus pleuropneumoniae, Serotype 2 (NSA252 Strain)........... 1,000,000,000 CFU   Serotype 5 (NSAS Strain) .............. 1,000,000,000 CFU Serotype 2 Toxin (NSA252 Strain) ... 10 ug   Serotype 5 Toxin (NSA5 Strain) ....... 10 ug CFU -Colony Forming Unit Suspension for Injection   (IM) Philippines - English - FDA (Food And Drug Administration)

suishot apm-7 each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit suspension for injection (im)

agrimate, inc.; distributor: agrimate, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - suspension for injection (im) - each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit

Porcilis AR-T DF Each (2 mL) dose contains:   Pasteurella multocida (Type D) dermo necrotic toxin deletion derivative (Protein Do)............... 26.2 log2 TN titer Bordetella bronchiseptica (Bb7 92932 Strain) .............   ...........   25.5 log2 Agglutination titer TN-Toxin Neutralization Suspension for Injection   (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis ar-t df each (2 ml) dose contains: pasteurella multocida (type d) dermo necrotic toxin deletion derivative (protein do)............... 26.2 log2 tn titer bordetella bronchiseptica (bb7 92932 strain) ............. ........... 25.5 log2 agglutination titer tn-toxin neutralization suspension for injection (im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated bordetella bronchiseptica vaccine (vet.) - suspension for injection (im) - each (2 ml) dose contains: pasteurella multocida (type d) dermo necrotic toxin deletion derivative (protein do)............... 26.2 log2 tn titer bordetella bronchiseptica (bb7 92932 strain) ............. ........... 25.5 log2 agglutination titer tn-toxin neutralization

Aradicator Formulation: Each 2 mL (dose) contains: Bordetella bronchiseptica (2-9 NADL Strain)................ >1.8 OU Pasteurella multocida (Type D) (Strain 8).................. >4.0 Cellsou Pasteurella multocida (Type D) (Strain 8)............... > 175 Toxoid RU  .  RU-Relative Units OU-Opacity Units Suspension for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

aradicator formulation: each 2 ml (dose) contains: bordetella bronchiseptica (2-9 nadl strain)................ >1.8 ou pasteurella multocida (type d) (strain 8).................. >4.0 cellsou pasteurella multocida (type d) (strain 8)............... > 175 toxoid ru . ru-relative units ou-opacity units suspension for injection (im)

zoetis philippines inc.; distributor: zoetis philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocidạ vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (2-9 nadl strain)................ >1.8 ou pasteurella multocida (type d) (strain 8).................. >4.0 cellsou pasteurella multocida (type d) (strain 8)............... > 175 toxoid ru . ru-relative units ou-opacity units

Nobilis Newcavac Formulation:   Each dose contains: Inactivated Newcastle Disease Virus (NDV) La Sota (Clone 30 Strain) .......................................> 50 PD50 PD-Protective Dose Emulsion for   Injection (SC/IM) Philippines - English - FDA (Food And Drug Administration)

nobilis newcavac formulation: each dose contains: inactivated newcastle disease virus (ndv) la sota (clone 30 strain) .......................................> 50 pd50 pd-protective dose emulsion for injection (sc/im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated newcastle disease virus (ndv) vaccine (vet.) - emulsion for injection (sc/im) - formulation: each dose contains: inactivated newcastle disease virus (ndv) la sota (clone 30 strain) .......................................> 50 pd50 pd-protective dose

Biofel PCH Formulation:   Each dose (1 mL) contains:   Inactivated Feline Panleukopenia (FP) Virus (FPV-Bio 7 strain) .......... <10^3 TCID50 Feline Calicivirus (FCV) (FCV-Bio 8 strain) ...............< 10^5.5 TCIDO Feline Herpesvirus (FHV) (FHV-1-Bio 9)........<10% TCID50 TCID - Median Tissue Culture Infectious Dose Emulsion for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biofel pch formulation: each dose (1 ml) contains: inactivated feline panleukopenia (fp) virus (fpv-bio 7 strain) .......... <10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ...............< 10^5.5 tcido feline herpesvirus (fhv) (fhv-1-bio 9)........<10% tcid50 tcid - median tissue culture infectious dose emulsion for injection (sc)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) vaccine (vet.) - emulsion for injection (sc) - formulation: each dose (1 ml) contains: inactivated feline panleukopenia (fp) virus (fpv-bio 7 strain) .......... <10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ...............< 10^5.5 tcido feline herpesvirus (fhv) (fhv-1-bio 9)........<10% tcid50 tcid - median tissue culture infectious dose

Biofel PCHR : Formulation:   Each mL (dose) contains:   Inactivated Feline Panleukopenia Virus (FPV) (FPV-Bio 7 strain) ....... > 10^3 TCID50 Feline Calicivirus (FCV) (FCV-Bio 8 strain) ............. > 10^5.5 TCID 50 Feline Herpesvirus (FHV) (FHV-1-Bio 8).............. > 10^5 TCID 50 Rabies Virus (MSV Bio 16-Vnukovo-32 strain)........... >.1 IU TCID - Tissue Culture Infectious Dose IU - International Unit Emulsion for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biofel pchr : formulation: each ml (dose) contains: inactivated feline panleukopenia virus (fpv) (fpv-bio 7 strain) ....... > 10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ............. > 10^5.5 tcid 50 feline herpesvirus (fhv) (fhv-1-bio 8).............. > 10^5 tcid 50 rabies virus (msv bio 16-vnukovo-32 strain)........... >.1 iu tcid - tissue culture infectious dose iu - international unit emulsion for injection (sc)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) , rabies virus (rv) vaccine (vet.) - emulsion for injection (sc) - : formulation: each ml (dose) contains: inactivated feline panleukopenia virus (fpv) (fpv-bio 7 strain) ....... > 10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ............. > 10^5.5 tcid 50 feline herpesvirus (fhv) (fhv-1-bio 8).............. > 10^5 tcid 50 rabies virus (msv bio 16-vnukovo-32 strain)........... >.1 iu tcid - tissue culture infectious dose iu - international unit